| 摘要 |
L'INVENTION CONCERNE L'INDUSTRIE PHARMACEUTIQUE.ELLE A POUR OBJET DES COMPOSES DE FORMULE:<BR/>(CF DESSIN DANS BOPI)<BR/>PAR EXEMPLE, LE 5-(4,5-DIHYDRO-4,4-DIMETHYL-2-OXAZOLYL)-6-ETHYL-1,4-DIHYDRO-2-METHYL-4 - (3-NITROPHENYL) - 3-PYRIDINECARBOXYLATE D'ETHYLE; LE 5-(4,5-DIHYDRO-4,4-DIMETHYL-2-OXAZOLYL)-6-ETHYL-4-(2-FURANNYL)-1,4-DIHYDRO-2-METHYL-3-PYRIDINECARBOXYLATE D'ETHYLEOU LE 5-(4,5-DIHYDRO-4,4-DIMETHYL-2-OXAZOLYL)-6-ETHYL-1,4-DIHYDRO-2-METHYL-4-(4-NITROPHENYL)-3-PYRIDINECARBOXYLATE D'ETHYLE.CES COMPOSES SONT PREFERES COMME VASODILATATEURS.
|
